Group 2354.png

Patient counselling

STANDING UP TO LDL-C

It’s important to keep track of LDL-C levels. This guide can help you have an open and honest conversation with your patient about taking the next step toward lowering LDL-C.

Ask these quick questions to your patient, so together you can decide the best path forward for your patient

Frame 427318837.png

EDA Approval No: WF0424OA5708/042026 EDA Invalidation Date:06/04/2027

References

  1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2020 Jan 1;41(1):111-88.. Available at: https://academic.oup.com/eurheartj/article/41/1/111/5556353 . Last accessed:16/09/2025.

Adverse Events Reporting

We encourage using the following Electronic reporting tool for reporting into the safety database directly:
If the electronic reporting tool is not working - please use the following: https://www.report.novartis.com
1 - Generic Mailbox: [email protected]
2 - CISCO: +20 2 2 2861000: Press 3 for Adverse Events Reporting